↓ Skip to main content

Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis

Overview of attention for article published in BMC Medicine, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
Published in
BMC Medicine, April 2011
DOI 10.1186/1741-7015-9-36
Pubmed ID
Authors

Simone Lanini, Aoife C Molloy, Paul E Fine, Archibald G Prentice, Giuseppe Ippolito, Christopher C Kibbler

Abstract

The addition of Rituximab (R) to standard chemotherapy (C) has been reported to improve the end of treatment outcome in patients affected by CD-20 positive malignant lymphomas (CD20+ ML). Nevertheless, given the profound and prolonged immunosuppression produced by R there are concerns that severe infections may arise. A systematic review and meta-analysis were performed to determine whether or not the addition of R to C may increase the risk of severe infections in adults undergoing induction therapy for CD20+ ML.

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 2%
Brazil 1 2%
Unknown 62 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 23%
Other 8 13%
Student > Ph. D. Student 6 9%
Student > Bachelor 5 8%
Student > Postgraduate 5 8%
Other 15 23%
Unknown 10 16%
Readers by discipline Count As %
Medicine and Dentistry 34 53%
Nursing and Health Professions 3 5%
Agricultural and Biological Sciences 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 4 6%
Unknown 16 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2011.
All research outputs
#503,399
of 3,685,110 outputs
Outputs from BMC Medicine
#611
of 1,020 outputs
Outputs of similar age
#14,004
of 85,550 outputs
Outputs of similar age from BMC Medicine
#58
of 85 outputs
Altmetric has tracked 3,685,110 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,020 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 85,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.